Abstract
Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number.
Michael J Wasserman, Deborah A Weber, Judith A Guthrie, Vivian P Bykerk, Peter Lee and Edward C Keystone
The Journal of Rheumatology October 2004, 31 (10) 1912-1917;
Michael J Wasserman
Deborah A Weber
Judith A Guthrie
Vivian P Bykerk
Peter Lee
In this issue
Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number.
Michael J Wasserman, Deborah A Weber, Judith A Guthrie, Vivian P Bykerk, Peter Lee, Edward C Keystone
The Journal of Rheumatology Oct 2004, 31 (10) 1912-1917;
Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number.
Michael J Wasserman, Deborah A Weber, Judith A Guthrie, Vivian P Bykerk, Peter Lee, Edward C Keystone
The Journal of Rheumatology Oct 2004, 31 (10) 1912-1917;